A detailed history of Sp Asset Management transactions in Abb Vie Inc. stock. As of the latest transaction made, Sp Asset Management holds 186,903 shares of ABBV stock, worth $33.6 Million. This represents 3.43% of its overall portfolio holdings.

Number of Shares
186,903
Previous 173,590 7.67%
Holding current value
$33.6 Million
Previous $26.6 Million 5.65%
% of portfolio
3.43%
Previous 3.39%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 08, 2022

BUY
$134.21 - $153.93 $1.79 Million - $2.05 Million
13,313 Added 7.67%
186,903 $25.1 Million
Q2 2022

Aug 03, 2022

BUY
$137.62 - $174.96 $33,304 - $42,340
242 Added 0.14%
173,590 $26.6 Million
Q1 2022

May 09, 2022

BUY
$131.98 - $163.75 $236,772 - $293,767
1,794 Added 1.05%
173,348 $28.1 Million
Q4 2021

Feb 02, 2022

BUY
$107.43 - $135.93 $201,323 - $254,732
1,874 Added 1.1%
171,554 $23.5 Million
Q3 2021

Oct 28, 2021

BUY
$106.4 - $120.78 $4.02 Million - $4.57 Million
37,825 Added 28.69%
169,680 $18.4 Million
Q2 2021

Jul 28, 2021

BUY
$105.21 - $117.21 $319,312 - $355,732
3,035 Added 2.36%
131,855 $15.6 Million
Q1 2021

May 05, 2021

BUY
$102.3 - $112.62 $950,367 - $1.05 Million
9,290 Added 7.77%
128,820 $14.8 Million
Q4 2020

Feb 08, 2021

BUY
$80.49 - $108.67 $105,924 - $143,009
1,316 Added 1.11%
119,530 $13 Million
Q3 2020

Nov 06, 2020

BUY
$85.91 - $100.83 $2.32 Million - $2.72 Million
27,011 Added 29.62%
118,214 $11.1 Million
Q2 2020

Aug 14, 2020

BUY
$73.37 - $98.18 $81,147 - $108,587
1,106 Added 1.23%
91,203 $8.95 Million
Q1 2020

May 13, 2020

BUY
$64.5 - $97.79 $306,181 - $464,209
4,747 Added 5.56%
90,097 $6.86 Million
Q4 2019

Feb 12, 2020

SELL
$72.13 - $90.25 $22,504 - $28,158
-312 Reduced 0.36%
85,350 $7.56 Million
Q3 2019

Nov 01, 2019

BUY
$62.98 - $75.72 $103,602 - $124,559
1,645 Added 1.96%
85,662 $6.49 Million
Q2 2019

Aug 13, 2019

BUY
$65.7 - $83.98 $91,980 - $117,572
1,400 Added 1.69%
84,017 $6.11 Million
Q1 2019

May 09, 2019

SELL
$77.14 - $90.79 $66,340 - $78,079
-860 Reduced 1.03%
82,617 $6.66 Million
Q4 2018

Feb 08, 2019

BUY
$77.85 - $96.01 $400,226 - $493,587
5,141 Added 6.56%
83,477 $7.7 Million
Q3 2018

Nov 13, 2018

SELL
$88.91 - $98.84 $20,004 - $22,239
-225 Reduced 0.29%
78,336 $7.4 Million
Q2 2018

Sep 07, 2018

BUY
$89.78 - $106.23 $7.05 Million - $8.35 Million
78,561 New
78,561 $7.4 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Sp Asset Management Portfolio

Follow Sp Asset Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sp Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Sp Asset Management with notifications on news.